GRPH - Graphite Bio, Inc. Stock Price, Fair Value and News

$35.50+1.18 (+3.44%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

GRPH Price Action

Last 7 days

6.9%

Last 30 days

41.9%

Last 90 days

57.8%

Trailing 12 Months

118.6%

GRPH RSI Chart

GRPH Valuation

Market Cap

976.3M

Price/Earnings (Trailing)

-31.21

EV/EBITDA

-10.32

Price/Free Cashflow

-17.4

MarketCap/EBT

-11.23

GRPH Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

GRPH Fundamentals

GRPH Earnings

Earnings (TTM)

-31.3M

Earnings Growth (Yr)

54.57%

Earnings Growth (Qtr)

0.38%

GRPH Profitability

Return on Equity

-14.53%

Return on Assets

-13.96%

Free Cashflow Yield

-5.75%

GRPH Investor Care

Shares Dilution (1Y)

231.93%

Diluted EPS (TTM)

-25.37

Revenue & Growth

About Graphite Bio, Inc.

Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH102 for the treatment of beta-thalassemia; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

CEO	Ms. Kimberlee Cobleigh Drapkin CPA, CPA
WEBSITE	https://graphitebio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	120

Graphite Bio, Inc. Frequently Asked Questions

What is the ticker symbol for Graphite Bio, Inc.? What does GRPH stand for in stocks?

GRPH is the stock ticker symbol of Graphite Bio, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Graphite Bio, Inc. (GRPH)?

As of Fri Nov 22 2024, market cap of Graphite Bio, Inc. is 976.28 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GRPH stock?

You can check GRPH's fair value in chart for subscribers.

Is Graphite Bio, Inc. a good stock to buy?

The fair value guage provides a quick view whether GRPH is over valued or under valued. Whether Graphite Bio, Inc. is cheap or expensive depends on the assumptions which impact Graphite Bio, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GRPH.